Here are the 424B prospectus supplements from Mannkind Corporation (MNKD) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow MNKD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MNKD filings page.
MannKind Corporation (MNKD) has filed a prospectus supplement registering for resale up to 12,853,470 shares of common stock by existing selling stockholders. This total includes 10,440,838 issued shares and 2,412,632 shares issuable upon exercise of outstanding pre-funded warrants from a July 24, 2026 private placement.
The company sold the private placement securities at $3.89 per common share and $3.88 per pre-funded warrant, with each pre-funded warrant carrying a $0.01 exercise price and no expiration until exercised, subject to a beneficial ownership limitation not to exceed 19.99%. MannKind will not receive any proceeds from the resale of these shares, though it is paying the registration and related offering expenses.
The selling stockholders may dispose of shares through various methods, including market and negotiated transactions, and may use underwriters, broker-dealers or agents. MannKind’s common stock trades on the Nasdaq Global Market under the symbol MNKD; the last reported sale price was $4.26 per share on August 20, 2026. Shares outstanding were 321,544,484 as of August 14, 2026, a baseline figure distinct from the shares registered for resale.